Literature DB >> 28615237

Erratum. Combination Therapy With Exenatide Plus Pioglitazone Versus Basal/Bolus Insulin in Patients With Poorly Controlled Type 2 Diabetes on Sulfonylurea Plus Metformin: The Qatar Study. Diabetes Care 2017;40:325-331.

Muhammad Abdul-Ghani, Osama Migahid, Ayman Megahed, John Adams, Curtis Triplitt, Ralph A DeFronzo, Mahmoud Zirie, Amin Jayyousi.   

Abstract

Entities:  

Year:  2017        PMID： 28615237      PMCID： PMC5521968          DOI： 10.2337/dc17-er08d

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
In the above-mentioned article, Fig. 1A was corrected (the colors in the panel were switched) to be consistent with panel 1B and with the text, and panel 1C had a missing double asterisk added. The online version of the figure has been corrected to reflect these changes.
  1 in total

1.  Comparative Study on Adding Pioglitazone or Sitagliptin to Patients with Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin.

Authors:  Maryam Jameshorani; Saba Sayari; Narjes Kiahashemi; Nima Motamed
Journal:  Open Access Maced J Med Sci       Date:  2017-12-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.